Clinical trial · Observational
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
NCT02313623CI-TRIAL-00103131completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. These profiles will in turn enable better predictions of the malignant progression of prostate cancers in the settings of current clinical practice.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Prostate Fusion Biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patient Scheduled for Prostate Fusion Biopsies
- description
- For subjects with scheduled fusion biopsies, we propose a research plan to acquire additional biopsy cores for research purposes without impacting clinical protocol. After acquiring clinically-necessary biopsies, we propose taking an additional research biopsy to establish a matched-pair of clinical and research samples.
- interventionNames
- Procedure: Prostate Fusion Biopsy
Primary outcomes (1)
- measure
- Success Rate of Primary Prostate Cell Culture
- timeFrame
- 2 years
- description
- how often are primary prostate cancer cells able to be grown in culture
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Only subjects that have scheduled Artemis prostate biopsy with defined regions of interest will be included in this study Exclusion Criteria: * Any subjects that are unable to provide informed consent will be excluded
References
Publications (0)
Data not yet available
No reference posted for this study.